Development of a PEGylated-based Platform for Efficient Delivery of

Development of a PEGylated-based Platform for Efficient Delivery of. Dietary Antioxidants Across the Blood–Brain ... PEGAntiOxs can cross hCMEC/D3 m...
4 downloads 6 Views 1MB Size
Subscriber access provided by Eastern Michigan University | Bruce T. Halle Library

Development of a PEGylated-based Platform for Efficient Delivery of Dietary Antioxidants Across the Blood–Brain Barrier Fernanda M. Borges, Carlos Fernandes, Miguel Pinto, Claudia Martins, Maria João Gomes, Bruno Sarmento, Paulo Oliveira, and Fernando Remião Bioconjugate Chem., Just Accepted Manuscript • DOI: 10.1021/acs.bioconjchem.8b00151 • Publication Date (Web): 11 Apr 2018 Downloaded from http://pubs.acs.org on April 11, 2018

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 38 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Bioconjugate Chemistry

Development of a PEGylated-based Platform for Efficient Delivery of Dietary Antioxidants Across the Blood–Brain Barrier Carlos Fernandesa, Miguel Pintoa, Cláudia Martinsb,c, Maria João Gomesb,c,d, Bruno Sarmentob,c,e, Paulo J. Oliveiraf, Fernando Remiãog, Fernanda Borgesa* a

CIQUP, Centro de Investigação em Química, Departmento de Química e Bioquímica,

Faculdade de Ciências, Universidade do Porto, 4169-007, Porto, Portugal. b

i3S, Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-393

Porto, Portugal c

INEB, Instituto de Engenharia Biomédica, Nanomedicines & Translational Drug

Delivery Group, Universidade do Porto, 4200-393 Porto, Portugal d

ICBAS, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-

313 Porto, Portugal e

CESPU, Instituto de Investigação e Formação Avançada em Ciências e Tecnologias da

Saúde, 4585-116 Gandra, Portugal f

CNC-Center for Neuroscience and Cell Biology, UC-Biotech, University of Coimbra,

Biocant Park, 3060-197 Cantanhede, Portugal. g

UCIBIO-REQUIMTE, Laboratório de Toxicologia, Departamento de Ciências

Biológicas, Faculdade de Farmácia, Universidade do Porto, 4050-313, Porto, Portugal.

Corresponding Author: Fernanda Borges, CIQUP/Departmento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, 4169-007, Porto, Portugal. E-mail: [email protected]

1 ACS Paragon Plus Environment

Bioconjugate Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 2 of 38

ABSTRACT The uptake and transport of dietary antioxidants remains the most important setback for their application in the therapy. To overcome the limitations a PEGylated-based platform was developed to improve the delivery properties of two dietary hydroxycinnamic (HCA) antioxidants - caffeic and ferulic acids. The antioxidant properties of the new polymerantioxidant conjugates (PEGAntiOxs), prepared by linking polyethylene glycol (PEG) to the cinnamic acids by a one-step Knovenagel condensation reaction, were evaluated. PEGAntiOxs present a higher lipophilicity than the parent compounds (caffeic and ferulic acids) and similar, or higher, antioxidant properties. PEGAntiOxs, were not cytotoxic, at the tested concentrations, in SH-SY5Y, Caco-2 and hCMEC/D3 cells. Contrarily, cytotoxic effects in hCMEC/D3 and SH-SY5Y cells were observed, at 50 and 100 µM, for caffeic and ferulic acids. PEGAntiOxs operate as antioxidants against several oxidative stress-cellular inducers in a neuronal cell-based model, and were able to inhibit glycoprotein-P in Caco-2 cells. PEGAntiOxs can cross hCMEC/D3 monolayer cells, a model of the blood-brain barrier (BBB) endothelial membrane. In summary, PEGAntiOxs are valid antioxidant prototypes that can uphold the antioxidant properties of HCAs, reduce their cytotoxicity and improve their BBB permeability. PEGAntiOxs can be used in a next future as drug candidates to prevent or slow oxidative stress associated to neurodegenerative diseases.

*To whom correspondence should be addressed. Phone: +351 220402560. Fax: +351 220402659. E-mail: [email protected];

2 ACS Paragon Plus Environment

Page 3 of 38 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Bioconjugate Chemistry

INTRODUCTION Neurodegenerative disorders are amongst the most debilitating diseases of this century and are related with sporadic and/or familial conditions that are characterized by neuronal damage.(1) Although the etiology of these diseases has not yet been fully understood, oxidative stress, induced by imbalanced redox states involving either excessive generation of reactive oxygen species (ROS) or dysfunction of the endogenous antioxidant system, has been linked to the pathophysiological events. Brain is one of the most metabolically active organs vulnerable to oxidative stress, a process that has deleterious effects as it can induce cellular damage, impairment of the DNA repair system and mitochondrial dysfunction, among others. During the progression of age-related neurodegenerative conditions, the capacity of cells to maintain the redox balance decreases and in consequence the cascade of oxidative stress events upsurge contributing for disease progression.(2, 3) As oxidative damage pathways constitute a complex network the blockage at different levels with diverse types of antioxidants can be beneficial. Thus, antioxidant therapy has been proposed as a promising approach for delaying or slowing the neurodegeneration progression.(1) The up-regulation of the pool of endogenous antioxidants or the intake of exogenous dietary antioxidants, such as hydroxycinnamic acids (HCAs), have been stated as an effective strategy for delaying or slowing the degenerative progression of neurons.(4) In fact, it is assumed that a regular consumption of fruits and vegetables, commonly attributed to the phenolic antioxidants, is linked with neuroprotective benefits. However, the majority of antioxidants studied so far have limited success in clinical trials, a fact that could be related with their poor distribution and with the inherent difficulties to cross the brain-blood barrier (BBB) and attain the target sites.(5) The BBB is considered the most important barrier to protect the brain, constituting a rate-limiting factor in the transport of drugs into the central nervous system.(6) The large BBB surface area of the endothelial membrane offers an effective transcellular passive diffusion pathway for lipid-soluble agents and small gaseous molecules, whereas the entry of hydrophilic molecules is generally repressed.(7) Around 98 % of small molecules (molecular weight